Live Pharmaceuticals Sustainability Dashboard
Live Average annual emissions trends for Pharmaceuticals
This chart illustrates the average industry Carbon emissions (Actual emissions published on Ecodesk). A higher average line often illustrates a greater measurement boundary – i.e. more overall responsibility.
Live Scope 1, 2 & 3 emissions data for Pharmaceuticals
Companies in blue have accounted for all 15 subcategories of WBCSD/WRI recommendations for Scope 3 reporting (see "Edit my profile". Scope 3 means indirect responsibility including manufacturing, use and recycling among other categories). Those in white have not yet accounted for all subcategories. "Accounted for" means either fully reported or not applicable.
Latest Scope analysis for 2011
The outer pie shows the relative number of organisations reporting S1, S2 and S3, (where S1 = 100). Some organisations report one figure denoting all three scopes. The inner pie shows the company, country or industry sector in this profile.
- Outer: Healthcare sector average
- Inner: Pharmaceuticals
The data which forms the graphics in Ecodesk is aggregated live and automatically from company profiles already published. Ecodesk Live picks the latest available complete year for data comparison.
For example, 2011 data has not yet been reported by most organisations - hence the low data line It should NOT be considered a total figure of any sector or country.
| Company | Staff | Revenue USD | Carbon Mt CO2-e | Energy Gj | Water m3 | Waste t | ||
|---|---|---|---|---|---|---|---|---|
| Alliance Boots | 116,000 | 35,850,960,000 USD | 416,391 | 2,833,200 | – | 70,150 | View Profile » | |
| Johnson & Johnson | 114,000 | 61,587,000,000 USD | 1,280,000 | – | 11,300,000 | 81,900 | View Profile » | |
| Pfizer | 110,000 | 1,241,000,000 USD | 2,700,000 | – | 20,000,000 | 265,000 | View Profile » | |
| Sanofi-Aventis | 101,575 | 41,100,000,000 USD | 1,252,901 | 17,236,424 | 54,090,658 | 230,843 | View Profile » | |
| Merck | 100,000 | 27,428,300,000 USD | 2,140,000 | 27,666,000 | 33,596,000 | 140,000 | View Profile » | |
| GlaxoSmithKline | 97,389 | 42,573,026,725 USD | 6,973,000 | 17,300,000 | 17,400,000 | 58,321 | View Profile » | |
| Abbott Laboratories | 91,440 | 35,167,000,000 USD | 1,609,000 | 20,096,000 | – | 119,178 | View Profile » | |
| Roche Group | 80,653 | 49,400,000,000 USD | 1,077,794 | 14,495,000 | 19,667,601 | 56,269 | View Profile » | |
| AstraZeneca | 61,000 | 33,269,000,000 USD | 1,080,000 | 7,582,000 | 4,000,000 | 44,000 | View Profile » | |
| Merck KGaA | 40,562 | 12,285,000,000 USD | 574,000 | 5,306,400 | 17,900,000 | 193,000 | View Profile » | |
| Show results: 5 10 15 50 100 Subscribe to view more results » | ||||||||
